News

September 20, 2018September 20, 2018

Efforts to Mark World Alzheimer’s Day, Sept. 21, and Month Are Well Underway

News

Individuals and organizations internationally are marking World Alzheimer’s Day, Sept. 21, by focusing efforts on increasing awareness and challenging stigmas about Alzheimer’s, the most common form of dementia. For ... Read more

September 17, 2018September 17, 2018

Nuplazid More Effective in Reducing Severe Psychosis in Alzheimer’s, Trial Shows

News

Nuplazid (pimavanserin) is more effective in reducing severe psychotic symptoms — particularly hallucinations and delusions — in Alzheimer’s disease patients than in those with milder symptoms, according to additional ... Read more

September 14, 2018September 14, 2018

Age, Gender, and APOE4 Variant May Help Identify Those at High Risk for Dementia, Study Suggests

News

The absolute 10-year risk of dementia varies according to age, gender, and common variation in the APOE gene, according to a large-scale Danish study. This discovery may help identify high-risk ... Read more

September 12, 2018September 12, 2018

Phase 3 Trial Results Suggest Flortaucipir Tracer Agent Can Help Predict Alzheimer’s Diagnosis

News

Flortaucipir, an investigational imaging agent, was able to efficiently detect Tau protein aggregates and related Alzheimer’s disease brain changes, meeting both of its primary objectives in a Phase 3 ... Read more

September 10, 2018September 10, 2018

Excessive Daytime Sleepiness Associated With Alzheimer’s Risk, Long-term Study Reports

News

Excessive daytime sleepiness or napping is associated with increased beta-amyloid plaques in the brain, a major characteristic of Alzheimer’s disease, according to a study that followed patients for more than ... Read more

September 7, 2018September 7, 2018

Peptide Found in Sea Anemones Might Give Rise to Alzheimer’s Treatment, Study Says

News

Small proteins found in sea anemones can protect nerve cells from the toxic effects of beta-amyloid, a hallmark of Alzheimer’s, and may one day point to a way of treating ... Read more

September 5, 2018September 5, 2018

Aducanumab Continues to Show Potential as Treatment for Mild Alzheimer’s in Long-term Extension of PRIME Trial

News

Latest results from the long-term extension of a Phase 1b study assessing increasing and fixed doses of aducanumab continue to show its potential as a therapy for early or ... Read more

August 31, 2018August 31, 2018

Non-Invasive Eye Exam Might Help Predict Risk for Alzheimer’s, Study Suggests

News

A non-invasive eye exam, similar to those given in eye doctors’ offices, might someday help predict a person’s risk of developing Alzheimer’s disease, a new study suggests. The study, ... Read more

August 29, 2018August 29, 2018

Synaptic Protein Makeup May Explain Why Not All People with Alzheimer’s Brain Markers Develop Dementia

News

Scientists have discovered why some people who have brain markers of Alzheimer’s disease, such as protein plaques and tangles, do not develop dementia. The reason may lie in the structure of ... Read more

August 27, 2018August 27, 2018

ProMIS’ PMN310 Shows Improved Safety Profile, Specificity Compared to Similar Alzheimer’s Candidates

News

ProMIS Neurosciences’ lead therapeutic candidate for Alzheimer’s disease, PMN310, showed an improved safety profile when directly compared to other amyloid-beta directed antibodies, according to preclinical study results. Unlike BAN2401 (Biogen, Eisai) ... Read more

Pin It on Pinterest